When was Sagacity Diagnostics founded?

Sagacity Diagnostics was founded in 2025.

Where is Sagacity Diagnostics located?

Sagacity Diagnostics is headquartered in Castle Rock, United States.

Where does Sagacity Diagnostics rank among its competitors?

Sagacity Diagnostics ranks 12th amongst 14 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Aethelgard Marambio Orbital, which secured $20K in Sep, 2026.

Who are the top competitors of Sagacity Diagnostics?

Sagacity Diagnostics' top competitors include Mendelian, PhiTech and Volv Global. Among them, Aethelgard Marambio Orbital secured the most recent funding round in September, 2026.

Sagacity Diagnostics - 2026 Company Profile & Competitors

Company Details

Developer of clinical decision support software for rare disease identification. The platform applies artificial intelligence and expert-curated disease pathways to existing electronic health records and real-world data. It identifies candidate patients who match specific clinical profiles, surfacing supporting evidence for independent review by qualified clinicians. The software operates within secure health system environments, utilizing standard health data formats to ensure auditability and reproducibility. This technology assists healthcare providers and research organizations in locating undiagnosed individuals to improve clinical pathways. The engine remains focused on processing historical clinical records to assist in diagnostic decision-making processes.

Key Metrics

Founded Year

2025

Location

Castle Rock, United States

Stage

Unfunded

Ranked

12^th among 14 active competitors

Similar Companies

Mendelian & 12 more

View Sagacity Diagnostics' full profile

Sagacity Diagnostics has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sagacity Diagnostics include Mendelian, PhiTech and Volv Global. Here is the list of Top 10 competitors of Sagacity Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Mendelian 2015, London (United Kingdom), Funding Raised	Developer of an online platform that helps health care provider in diagnosing rare disease	-	Crista Galli Ventures, P4 & 5 others	48/100
2nd	PhiTech 2013, Gebze (Turkey), Series A	Developer of RNA-Seq based diagnostic decision support platform for diseases	$1.35M	Arya Women, Eksim Ventures & 6 others	45/100
3rd	Volv Global 2017, Epalinges (Switzerland), Funding Raised	Provider of AI and machine learning solutions for healthcare insights	-	Seedlink	39/100
4th	RareSum 2024, Istanbul (Turkey), Funding Raised	Platform offering tools to rare disease diagnostics	-	Sabanc ARF	24/100
5th	Aethelgard Marambio Orbital 2026, Santiago (Chile), Seed	Developer of artificial intelligence software for identifying rare medical conditions	$20K	-	24/100
6th	Genengine 2018, Malaga (Spain), Unfunded	Provider of genetic-based clinical decision platform for personalised medicine	-	-	24/100
7th	RareMD 2016, Carlsbad (United States), Unfunded	AI-driven rare disease-focused differential diagnosis tool	-	-	21/100
8th	RDCom 2020, Buenos Aires (Argentina), Unfunded	Digital solutions for diagnosis and treatment of rare diseases	-	-	21/100
9th	Rarus 2019, Santiago (Chile), Unfunded	Provider of support platform for rare disease patients and their families	-	-	19/100
10th	GeniApp Milan (Italy), Unfunded	Developer of mobile applications for clinical diagnosis of rare diseases	-	-	18/100
12th	Sagacity Diagnostics 2025, Castle Rock (United States), Unfunded	Developer of clinical decision support software for rare disease identification	-	-	16/100